What essential medicines should a general practitioner stock for a small primary‑care clinic?

Essential Medicines for a Small Primary Care Clinic

For a small general practice clinic, you should stock a core formulary based on the WHO Essential Medicines List (EML) framework, prioritizing antibiotics from the "Access" category, basic analgesics, antihypertensives, diabetes medications, and emergency drugs that address the most common primary care presentations while maintaining supply chain resilience.

Core Antibiotic Formulary (Access Category Priority)

The WHO EML emphasizes universal access to quality-assured antibiotics, with the "Access" category representing first-line agents that should be widely available 1. Your antibiotic stock should include:

Beta-lactams (First-Line)

• Amoxicillin (oral formulations): The cornerstone antibiotic for respiratory infections, with dosing at 45-90 mg/kg/day depending on resistance patterns 1
• Amoxicillin-clavulanate: Essential for beta-lactamase producing organisms, particularly in respiratory and urinary infections 1
• Cephalexin: Alternative for skin/soft tissue infections and step-down therapy 1

Macrolides

• Azithromycin: Preferred for atypical respiratory pathogens (Mycoplasma, Chlamydia) with convenient dosing 1
• Clarithromycin or Erythromycin: Alternatives when azithromycin unavailable 1

Other Key Antibiotics

• Doxycycline: For patients >7 years with atypical infections and as alternative therapy 1
• Clindamycin: Critical for penicillin-allergic patients and methicillin-resistant Staphylococcus aureus (MRSA) when susceptible 1
• Sulfamethoxazole-trimethoprim: Only in communities with known susceptibility patterns and low resistance rates 1

Important caveat: The Pediatric Infectious Diseases Society emphasizes limiting antibiotic spectrum to specifically required coverage and using proper dosing to minimize resistance development 1. Clindamycin resistance is increasing in certain geographic areas, requiring local susceptibility awareness 1.

Essential Non-Antibiotic Medications

Analgesics and Anti-inflammatories

• Acetaminophen/Paracetamol: First-line analgesic and antipyretic
• Ibuprofen: NSAID for pain and inflammation
• Aspirin: Low-dose for cardiovascular prevention

Chronic Disease Management

• Metformin: First-line diabetes medication
• ACE inhibitors (e.g., lisinopril) or ARBs: Hypertension and cardioprotection
• Statins (e.g., atorvastatin, simvastatin): Lipid management
• Beta-blockers (e.g., metoprolol): Cardiovascular conditions
• Calcium channel blockers (e.g., amlodipine): Alternative antihypertensive

Respiratory Medications

• Salbutamol/Albuterol inhaler: Acute bronchospasm
• Inhaled corticosteroids: Asthma maintenance
• Oral corticosteroids (prednisone): Acute exacerbations

Gastrointestinal

• Proton pump inhibitors (omeprazole): Acid suppression
• Antiemetics (ondansetron, metoclopramide)
• Oral rehydration salts: Diarrheal illness

Emergency Medications

• Epinephrine auto-injector: Anaphylaxis
• Glucose/dextrose: Hypoglycemia
• Antihistamines (diphenhydramine): Allergic reactions

Supply Chain and Availability Considerations

Critical reality check: Essential medicines face significant availability challenges globally. Amoxicillin shortages have occurred even in high-income countries due to supply chain vulnerabilities 1. National essential medicines lists vary dramatically—ranging from 44 to 983 medicines per country—with differences only partially explained by country characteristics 2. This suggests opportunities exist to optimize your formulary based on local needs rather than arbitrary selection 2.

Practical Stocking Strategy

• Prioritize medicines with stable supply chains and multiple manufacturers
• Consider "vulnerable" versus "essential" distinctions when a drug's shortage risk is high 3
• Stock pediatric formulations when serving families, as these face particular shortage risks 1
• Maintain relationships with multiple suppliers to mitigate disruptions 4

Evidence-Based Selection Principles

The WHO EML has evolved from experience-based to evidence-based selection, incorporating public health relevance, efficacy, safety, and cost-effectiveness 5. For your clinic:

• Limit antibiotic exposure whenever possible to minimize resistance selection 1
• Use narrow-spectrum agents when appropriate rather than broad-spectrum alternatives 1
• Ensure proper dosing to achieve effective concentrations and prevent resistance 1
• Treat for shortest effective duration: 10-day courses are traditional, but shorter courses may suffice for mild disease 1

Geographic and Population Adaptations

Your specific formulary should account for:

• Local resistance patterns: Particularly for fluoroquinolone and beta-lactam resistance 1
• Regional disease prevalence: Adjust based on common presentations in your area 2
• Patient demographics: Age distribution affects formulation needs (pediatric vs. adult) 1
• Healthcare expenditure capacity: Influences access to newer agents 2

The substantial differences between national essential medicines lists (with most medicines listed by ≤10% of countries) indicate that local adaptation is both necessary and appropriate 2.